Assignee
CHONGQING GENRIX BIOPHARMACEUTICAL CO LTD
CN·2 granted patents·1 pending application·0 citations·filing 2019–2025
Top patents by PatentIndex Score
3 records- 0157US2025019421A1Pharmaceutical formulation comprising bispecific antibody against rabies virus g protein and preparation method thereforCHONGQING GENRIX BIOPHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 0250US12559556B1BCMA × CD3 T bispecific cell engagerCHONGQING GENRIX BIOPHARMACEUTICAL CO LTD·Filed 2025·Granted Feb 24, 2026·0 cites·27 claims
- 0342US12497455B2Anti-CD3E/BCMA bispecific antibody and use thereofCHONGQING GENRIX BIOPHARMACEUTICAL CO LTD·Filed 2019·Granted Dec 16, 2025·0 cites·13 claims
Join the waitlist — get patent alerts
Get an alert when CHONGQING GENRIX BIOPHARMACEUTICAL CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →